Chemotherapy drug shows “significant” improvement in melanoma patients in late-stage trial
BOUDRY, Switzerland — A Swiss subsidiary of drug maker Celgene Corp. said its chemotherapy drug produced "significant" improvement in progression-free survival in patients with a deadly skin cancer that had spread elsewhere in the body.
Celgene International Sarl announced the publication of abstracts from its phase-3 trial of Abraxane in melanoma patients in the journal of the Society for Melanoma Research, with plans to present the findings at an upcoming meeting of the organization. Abraxane is a formulation of the drug paclitaxel bound in the human protein albumin and free of solvents already approved for treating several other cancers.
"Metastatic melanoma presents significant treatment challenges due in part to limited therapies, low survival rates at diagnosis and no advances in chemotherapy in 37 years," University of Arizona professor of medicine and lead study investigator Evan Hersh said. "Despite advances with targeted treatment and immunotherapies, there is still a need for new agents, including chemotherapy treatments, for patients with metastatic melanoma."
The trial included patients with metastatic melanoma who had not received chemotherapy before, comparing them to patients receiving dacarbazine chemotherapy. Results of the trial indicate that Abraxane was more effective, Celgene said.
Walgreens re-ups alliance with American Diabetes Association through 2013
ALEXANDRIA, Va. — The American Diabetes Association on Wednesday announced that Walgreens has reaffirmed its commitment as a National Strategic Partner and will continue to help the program Stop Diabetes by supporting the association’s Type 2 diabetes prevention initiative for consumers called CheckUp America.
"Education is crucial for the prevention of type 2 diabetes," stated Larry Hausner, ADA CEO. "Since the alliance was formed in 2011, Walgreens has raised more than $1.6 million for the Association and has helped us reach out to communities with critical information through our educational initiatives."
Walgreens will support the expanded distribution of patient education materials and the development of a transit advertising campaign in select markets to encourage consumers to find out their risk for diabetes, ADA reported.
The relationship kicks off this November during American Diabetes Month, as Walgreens will be conducting a pin pad donation campaign when a debit or credit card is used for payment. Walgreens will also be continuing its commitment to education by participating in select American Diabetes Association Expos — free events for the public featuring education about healthy eating, active living and changing the future of diabetes. In addition to its commitment in educating the public, Walgreens will again be a national sponsor of Step Out: Walk to Stop Diabetes, and will encourage its employees to get out and walk as part of the Walgreens nationwide team for Step Out.
Supervalu banners partner locally with Iams Home 4 the Holidays to raise pet adoption awareness
MINNESOTA — A number of Supervalu banners on Friday announced that select locations will host Iams Home 4 the Holidays initiative on Nov. 2 and 3. As part of the events, neighborhood shelters will introduce shoppers to deserving puppies, kittens, dogs and cats that are up for adoption.
“[Supervalu] is committed to looking for ways to enrich the lives of our shoppers and their pets,” stated Lanny Hoffmeyer, Supervalu category director for paper and pet. “We are proud to once again partner with Home 4 the Holidays and give our customers an opportunity to connect with animals that can enhance their lives for years.”
“Most of us shop locally, so we know many of the people that shop at the Jewel in our neighborhood,” commented Jeanne DiCello of Libertyville’s Placing Paws of Illinois. “Partnering with our local grocery store is a good way to help bring recognition to our organization. We’re also able to talk about pet adoption, show some of our available animals and answer many questions on the spot in a friendly encounter.”